Skip to main content
. 2009 Aug 4;59(2):247–256. doi: 10.1007/s00262-009-0745-0

Fig. 2.

Fig. 2

CDR3 spectratypes of 24 TCR BV gene families within CD4+ and CD8+ T cells. a Representation of a healthy control, b pre- and post-treatment spectratype profiles of representation of patient treated by mIFL combination of bevacizumab. TCR BV gene families showing evidence of abnormal are underlined